Structure-Function Studies of the Proprotein Convertases: the Pro- and P-Domains BY

Total Page:16

File Type:pdf, Size:1020Kb

Structure-Function Studies of the Proprotein Convertases: the Pro- and P-Domains BY Structure-Function Studies of the Proprotein Convertases: The Pro- and P-domains BY Mei Zhong A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirernents of the degree of Doctoor of Philosopby O Mei Zhong, November 1999 Department of Medicine Division of Experimental Medicine McGill University Mootreal, Québec NationaJ Library Bibliothèque nationale 1*1 ofCanâda du Canada Acquisitions and Acquisitions et Bibliographie Seivices services bibliographiques 385 Wdington Street 395,nie Wellington OmwaON KlAOW OUawaON K1AûN4 canada Canada The author has granted a non- L'auteur a accordé une Licence non exclusive licence aiiowing the exclusive permettant à la National Libraty of Canada to Bibliothèque nationale du Canada de reproduce, loaa, distribute or seli reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electroaic formats. la forme de microfiche/film, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fiom it Ni la thèse ni des extraits substantiels may be printed or otherwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. Acknowledgments I am greatly indebted to my supervisor, Dr. Nobil 6. Seidah for giving me the chance to join his lob, for his guidance and support throughout the years, for his invaluable advice, encouragement and criticism. His enthusiasm, tirelessness will be a positive influence throughout rny career. It was an honor to work with him in a highly motivated, diverse environment. 1 thank al1 the members, former and present, in Chétien-Lazure- Seidah laboratories for their assistance, support and friendship throughout the years. Especially Dr. Majambu Mbikay, Dr. Claude Lazure, Dr. Michel Chrétien, Dr. Ajoy Basak, Dr. Scott Munzer, Suzanne Benjannet, Seyed J. Mowla, Maya Mamarbassi, Josée Hamelin, Diane Savaria, Annie Lemieux, Dany Gauthier, Eric Bergeron and Andrew Chen. 1 am also grateful to Ms. Sylvie Ernond for her cheerful and patient assistance in al1 secretarial matters. Special thanks to Jim Rochernont to whom 1 will always be indebted and with whom I always laughed, because his trip to China bound me to such a great lab with the most great people. Without him, it would have been impossible to have such a great memory. 1 thank the Protein Engineering Network Centres of Excellence of Canada for its f inancial support. I thank my thesis committee members, Dr. James Chromlish, Dr. Hugh Bennett, Dr. Yogesh Patel for their advice and directions. Last but not Icast, 1 thank my parents for raising and supporting me and giving me the f reedom to pursue my dream. My beloved boyf riend Dr. Hongyan An for his caring love, patient, and constant support. Abstract The proprotein convertases (PCs) are involved in the activation of a wide variety of precursors via limited proteolysis at either single or paired basic residues. a crucial regdatory process in both normal and disease States. Seven members of this farnily were identified including £brin, PC1, PC2, PC4, PACE4, PC5 and PC7. Al1 of which exhibit a signal peptide, a prosegment, a catalytic domain, a P-domain and a specific C-terminal segment. The present work concentrated on the characterization of two structural elernents, namely the prosegment and the P-domain, which are cntical for enzymatic function and cellular trafficking. We examined the biosynthesis, functional activity and cellular localization of two PACE4 isoforms generated by differential splicing, the Full length PACE4-A and the C-terminally truncated PACECCS that lacks 1 1 arnino acids at the end of its chaperone-like P-domain. Cellular expression demonstrated that PACE4-A codes for a functional secretable enzyme capable of cleaving pro7B2 into 7B2. However. PACE4-CS is not secreted and remains in the endoplasmic reticulurn as an inactive zymogen form, therefore emphasizing the importance of the integrity of the P-domain. The prosegment is presumed to act both as an intramolecular chaperone and an inhibitor of its parent enzyme. We purified recombinant prosegments of funn @Furin) and PC7 (pPC7) fiom bacteria. The inhibitory potencies and selectivities of the prosegments were tested in vitro and ex vivo. The pFurin and pPC7 are potent inhibitors (ICso low nM) of their parent enzymes. Whereas pPC7 is more selective than pFurin. Most of the inhibitory potency seems to reside at the C-terminal region immediately preceding the pcimary cleavage site of the prosegment with the Pl Arg playing a critical role. Furthemore, overexpression of prosegments in ce11 lines efficiently blocked precursor processing of the neurotrophins NGF and BDNF. For the first tirne our results showed that PC prosegments expressed ex vivo as independent domains could act in nuns to inhibit precursor maturation by intracellular PCs. in conclusion, the prosegrnent and the P- domain of PCs are cntical for PC zyrnogen activation, enzymatic activity and intracellular traffrcking. The prosegment study also presents a novel enzyme silencing strategy, which provides a novel approach to the treatment of a variety of pathologies. Les proprotéines convertases (PCs) sont impliquées dans l'activation d'une panoplie de précurseurs via la protéolyse limitée à des résidus basiques ou dibasiques, un processus essentiel à l'homéostasie ainsi que dans le développement de maladies. Sept membres de cette famille ont été identifiés dont furine, PCI, PC2, PC4, PACE4, PCS et PC7. Tous possèdent un peptide signal, un prosegment, un domaine catalytique. un P- domaine et un segment C-terminal spécifique. Le présent travail se concentre sur la caractérisation du prosegment et du P-domaine des PCs qui sont critiques pour leur activité enzymatique et leur trafic cellulaire. Nous avons examiné la biosynthèse, I'activité fonctionnelle et localisation cellulaire de deux isoformes de PACE4 générés par épissage alternatif, le PACE4 pleine longueur et la forme tronquée en C-terminal PACE4CS, qui manque 11 acides aminés à la fin de son P-domaine. La surexpression cellulaire de PACE4-A produit un enzyme fonctionnelle, sécrétée et capable de cliver le pro782 en 782. Cependant, PACE4-CS n'est pas sécrétée et reste sous forme de zymogène inactif démontrant l'importance de l'intégrité du P-domaine. Le prosegment agit possiblement comme chaperon intramoléculaire et inhibiteur de l'enzyme parentale. Nous avons purifié les prosegments recombinants de funne @Fuine) et PC7 @PC7) de bactéries. Le potentiel d'inhibition et la sélectivité des prosegrnents ont été testés in vitro et ex vivo. Le pFurine et le pPC7 sont des inhibiteurs efficaces (IClo de l'ordre du nM) de leur enzyme parentale. Le pPC7 montre une plus grande sélectivité que le pFurine. La majorité du potentiel inhibiteur semble résider dans la région C-terminale précédant immédiatement le site de coupure primaire du prosegment avec l'kg en Pl jouant un rôle critique. De plus, la surexpression de prosegments dans des lignées cellulaires bloquent efficacement la maturation des neurothrophines NGF et BDNF. Pour la première fois, nos résultats démontrent que les prosegments de PCs exprimés comme domaine indépendant, ex vivo, peuvent agir en pans pour inhiber la maturation effectuée par des PCs intracellulairement. En conclusion, le prosegrnent et le P-domaine des PCs sont critiques dans l'activation des PCs sous forme de zymogènes, pour leur activité enymatique et leur trafic intracellulaire. L'expression cellulaire du prosegment représente une nouvelle approche afin d'inhiber les convertases et pour le traitement d'une variété de pathologie. Preface This thesis is submitted to the McGill University Faculty of Graduate studies and Research. This thesis is presented according to manuscript-based thesis format: Candidates have the option of including, as part of the thesis, the text of one or more papers submitted, or to be submitted. for publication, or the clearly- duplicated text (not the reprints) of one or more published papers. These texts must conform to the "Guidelines for Thesis Preparation" with respect to font size, line spacing and margin sizes and must be bound together as an integrai part of the thesis. The thesis must be more than a collection of manuscripis. A11 cornponents must be integrated into a cohesive unit with a logical progression fiom one chapter to the next. In order to ensure that the thesis has continuity. connecting texts that provide logical bridges between the different papers are mandatory . The thesis mut conform to al1 other requirements of the "Guidelines for Thesis Preparation" in addition to the manuscripts The thesis must include the following: a table of contents; an abstract in English and French; an introduction which clearly States the rational and objectives of the research; a comprehensive review of the literature (in addition to that covered in the introduction to each paper); a fdconclusion and summary. As manuscripts for publication are freqwntly very concise documents. where appropriate, additional material mut be provided (e.g.. in appendices) in suficient detail to allow a clear and precise judgement to be made of the importance and originality of the research reported in the thesis. In general, when CO-authoredpapers are included in a thesis the candidate must have made a substantial contribution to al1 papers included in the thesis. In addition, the candidate is required to make an explicit statement in the thesis as to who contributed to such work and to what extent. This statement should appear in a single section entitled "Contributions of Authon" as a preface to the thesis. The supervisor must attest to the accuracy of this staternent at the doctoral oral defence. Since the task of the examiners is made more dificult in these cases, it is in the candidate's interest to clearly specify the responsibilities of al1 the authoa of the CO-authoredPapen.
Recommended publications
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Intracellular Peptides: from Discovery to Function
    e u p a o p e n p r o t e o m i c s 3 ( 2 0 1 4 ) 143–151 Available online at www.sciencedirect.com ScienceDirect journal homepage: http://www.elsevier.com/locate/euprot Intracellular peptides: From discovery to function a,∗ b a,c d,∗∗ Emer S. Ferro , Vanessa Rioli , Leandro M. Castro , Lloyd D. Fricker a Department of Pharmacology, Biomedical Sciences Institute, University of São Paulo, São Paulo, SP, Brazil b Special Laboratory of Applied Toxicology-CeTICS, Butantan Institute, São Paulo, SP, Brazil c Department of Biophysics, Federal University of São Paulo, São Paulo, SP, Brazil d Department of Molecular Pharmacology and Neuroscience, Albert Einstein College of Medicine, Bronx, NY, USA a r t i c l e i n f o a b s t r a c t Article history: Peptidomics techniques have identified hundreds of peptides that are derived from proteins Received 8 October 2013 present mainly in the cytosol, mitochondria, and/or nucleus; these are termed intracellular Received in revised form peptides to distinguish them from secretory pathway peptides that function primarily out- 29 November 2013 side of the cell. The proteasome and thimet oligopeptidase participate in the production and Accepted 14 February 2014 metabolism of intracellular peptides. Many of the intracellular peptides are common among mouse tissues and human cell lines analyzed and likely to perform a variety of functions Keywords: within cells. Demonstrated functions include the modulation of signal transduction, mito- Peptides chondrial stress, and development; additional functions will likely be found for intracellular Cell signaling peptides.
    [Show full text]
  • A Case of Prohormone Convertase Deficiency Diagnosed with Type 2 Diabetes
    Turkish CASE REPORT Archives of DOI: 10.14744/TurkPediatriArs.2020.36459 Pediatrics A case of prohormone convertase deficiency diagnosed with type 2 diabetes Gülin Karacan Küçükali1 , Şenay Savaş Erdeve1 , Semra Çetinkaya1 , Melikşah Keskin1 , Ayşe Derya Buluş2 , Zehra Aycan1 1Department of Pediatric Endocrinology, University of Health Science, Dr. Sami Ulus Obstetrics and Gynecology, Children’s Health and Disease Training and Research Hospital, Ankara, Turkey 2Department of Pediatric Endocrinology, University of Health Science, Keçiören Training and Research Hospital, Ankara, Turkey What is already known ABSTRACT on this topic? Prohormone convertase 1/3, encoded by the proprotein convertase subtilisin/kexin type 1 gene, • Prohormone convertase defi- is essential for processing prohormones; therefore, its deficiency is characterized by a defi- ciency is characterized by a de- ciency of variable levels in all hormone systems. Although a case of postprandial hypoglycemia ficiency of variable levels in all has been previously reported in the literature, prohormone convertase insufficiency with type hormone systems. 2 diabetes mellitus has not yet been reported. Our case, a 14-year-old girl, was referred due to • Postprandial hypoglycemia is a excess weight gain. She was diagnosed as having type 2 diabetes mellitus based on laboratory disorder of glucose metabolism test results. Prohormone convertase deficiency was considered due to the history of resistant reported in this disease. diarrhea during the infancy period and her rapid weight gain. Proinsulin level was measured as >700 pmol/L(3.60-22) during diagnosis. In genetic analysis, a c.685G> T(p.V229F) homozygous mutation in the PCSK1 gene was detected and this has not been reported in relation to this dis- order.
    [Show full text]
  • Electronic Supplementary Material (ESI) for Analyst. This Journal Is © the Royal Society of Chemistry 2020
    Electronic Supplementary Material (ESI) for Analyst. This journal is © The Royal Society of Chemistry 2020 Table S1.
    [Show full text]
  • 1.2.Obesity-Pathophysiology.Pdf
    What Is the Disease of Obesity? Obesity Pathophysiology Obesity Has Multiple Pathophysiologic Origins Epigenetic Environmental Genetic Obesity Sociocultural Physiologic Behavioral Bray GA, et al. Lancet. 2016;387:1947-1956. 2 Obesity Pathophysiology Genetic and Epigenetic Origins 3 Genetic Determinants of Obesity Supported by Genome-Wide Association Studies Gene Tissue expressed Gene product / role in energy balance MC4R Adipocyte, hypothalamus, liver Melanocortin 4 receptor / Appetite stimulation; monogenic cause of obesity ADRB3 Visceral adipose tissue β3-Adrenergic receptor / Regulates lipolysis PCSK1 Neuroendocrine cells (brain, Proprotein convertase 1 / Conversion of hormones (including insulin) pituitary and adrenal glands) into metabolically active forms BDNF Hypothalamus Brain-derived neurotrophic factor / Appetite stimulation; regulated by MC4R signaling and nutritional state LCT Intestinal epithelial cells Lactase / Digestion of lactose MTNR1B Nearly ubiquitous Melantonin receptor 1 B / Regulation of circadian rhythms TLR4 Adipocyte, macrophage Toll-like receptor 4 / Lipolysis, inflammatory reactions ENPP1 Nearly ubiquitous Ecotnucleotide pyrophosphatase/phosphodiesterase 1 / Inhibits tyrosine kinase activity of the insulin receptor, downregulating insulin signaling and decreasing insulin sensitivity FGFR1 Adipose, hypothalamus Fibroblast growth factor receptor 1 / Hypothalamic regulation of food intake and physical activity LEP, LEPR Adipocyte Leptin, leptin receptor / Appetite inhibition den Hoed M, Loos RJF. In: Bray GA, Bouchard
    [Show full text]
  • Discovery of an Allosteric Site on Furin, Contributing to Potent Inhibition: a Promising Therapeutic for the Anemia of Chronic Inflammation
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2014-07-01 Discovery of an Allosteric Site on Furin, contributing to Potent Inhibition: A Promising Therapeutic for the Anemia of Chronic Inflammation Andrew Jacob Gross Brigham Young University Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Chemistry Commons BYU ScholarsArchive Citation Gross, Andrew Jacob, "Discovery of an Allosteric Site on Furin, contributing to Potent Inhibition: A Promising Therapeutic for the Anemia of Chronic Inflammation" (2014). Theses and Dissertations. 6537. https://scholarsarchive.byu.edu/etd/6537 This Dissertation is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected]. Discovery of an Allosteric Site on Furin, Contributing to Potent Inhibition: A Promising Therapeutic for the Anemia of Chronic Inflammation Andrew J. Gross A dissertation submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Doctor of Philosophy Richard K. Watt, Chair Dixon J. Woodbury Roger G. Harrison Chad R. Hancock John T. Prince Department of Chemistry and Biochemistry Brigham Young University July 2014 Copyright © 2014 Andrew J. Gross All Rights Reserved ABSTRACT Discovery of an Allosteric site on Furin, Contributing to potent Inhibition: A promising Therapeutic for the Anemia of Chronic Inflammation Andrew J. Gross Department of Chemistry and Biochemistry, BYU Doctor of Philosophy Anemia of chronic inflammation (ACI) is a condition that develops in a setting of chronic immune activation. ACI is characterized and triggered by inflammatory cytokines and the disruption of iron homeostasis.
    [Show full text]
  • PCSK9 Biology and Its Role in Atherothrombosis
    International Journal of Molecular Sciences Review PCSK9 Biology and Its Role in Atherothrombosis Cristina Barale, Elena Melchionda, Alessandro Morotti and Isabella Russo * Department of Clinical and Biological Sciences, Turin University, I-10043 Orbassano, TO, Italy; [email protected] (C.B.); [email protected] (E.M.); [email protected] (A.M.) * Correspondence: [email protected]; Tel./Fax: +39-011-9026622 Abstract: It is now about 20 years since the first case of a gain-of-function mutation involving the as- yet-unknown actor in cholesterol homeostasis, proprotein convertase subtilisin/kexin type 9 (PCSK9), was described. It was soon clear that this protein would have been of huge scientific and clinical value as a therapeutic strategy for dyslipidemia and atherosclerosis-associated cardiovascular disease (CVD) management. Indeed, PCSK9 is a serine protease belonging to the proprotein convertase family, mainly produced by the liver, and essential for metabolism of LDL particles by inhibiting LDL receptor (LDLR) recirculation to the cell surface with the consequent upregulation of LDLR- dependent LDL-C levels. Beyond its effects on LDL metabolism, several studies revealed the existence of additional roles of PCSK9 in different stages of atherosclerosis, also for its ability to target other members of the LDLR family. PCSK9 from plasma and vascular cells can contribute to the development of atherosclerotic plaque and thrombosis by promoting platelet activation, leukocyte recruitment and clot formation, also through mechanisms not related to systemic lipid changes. These results further supported the value for the potential cardiovascular benefits of therapies based on PCSK9 inhibition. Actually, the passive immunization with anti-PCSK9 antibodies, evolocumab and alirocumab, is shown to be effective in dramatically reducing the LDL-C levels and attenuating CVD.
    [Show full text]
  • PACE4 Expression in Mouse Basal Keratinocytes Results in Basement Membrane Disruption and Acceleration of Tumor Progression
    Research Article PACE4 Expression in Mouse Basal Keratinocytes Results in Basement Membrane Disruption and Acceleration of Tumor Progression Daniel E. Bassi,1,3 Ricardo Lopez De Cicco,1 Jonathan Cenna,1 Samuel Litwin,2 Edna Cukierman,2 and Andres J.P. Klein-Szanto1,3 Departments of 1Pathology and 2Biomathematics and Biostatistics, and 3Tumor Cell Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania Abstract and studying the in vivo effects after overexpressing genes, such as h Collagen type IV degradation results in disruption and transforming growth factor- (3), epidermal growth factor receptor breakdown of the normal basement membrane architecture, (4), and insulin-like growth factor (5). a key process in the initiation of tumor microinvasion into the Proprotein convertases constitute a family of serine proteases that activate their cognate substrates by limited proteolysis at consensus connective tissue. PACE4, a proprotein convertase, activates # membrane type matrix metalloproteinases (MT-MMPs) that in sequence RXR/KR (6). Many of these, such as insulin-like growth turn process collagenase type IV. Because PACE4 is overex- factor-I (7) and its receptor (8), membrane-type matrix metal- pressed in skin carcinomas and in vitro overexpression of loproteinase (MT-MMP; refs. 9, 10), and integrins (11–14) have direct PACE4 resulted in enhanced invasiveness, we investigated roles in tumor progression and metastasis. Although proprotein whetherornotin vivo PACE4 expression leads to the convertases recognize and cleave a specific sequence, variations in the amino acid sequences that surround this motif, as well as acquisition of invasiveness and increased tumorigenesis. Two transgenic mouse lines were designed by targeting PACE4 to preferences in K or R preceding the COOH-terminal R, account for the epidermal basal keratinocytes.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan Et Al
    US 2004.008 1648A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan et al. (43) Pub. Date: Apr. 29, 2004 (54) ADZYMES AND USES THEREOF Publication Classification (76) Inventors: Noubar B. Afeyan, Lexington, MA (51) Int. Cl." ............................. A61K 38/48; C12N 9/64 (US); Frank D. Lee, Chestnut Hill, MA (52) U.S. Cl. ......................................... 424/94.63; 435/226 (US); Gordon G. Wong, Brookline, MA (US); Ruchira Das Gupta, Auburndale, MA (US); Brian Baynes, (57) ABSTRACT Somerville, MA (US) Disclosed is a family of novel protein constructs, useful as Correspondence Address: drugs and for other purposes, termed “adzymes, comprising ROPES & GRAY LLP an address moiety and a catalytic domain. In Some types of disclosed adzymes, the address binds with a binding site on ONE INTERNATIONAL PLACE or in functional proximity to a targeted biomolecule, e.g., an BOSTON, MA 02110-2624 (US) extracellular targeted biomolecule, and is disposed adjacent (21) Appl. No.: 10/650,592 the catalytic domain So that its affinity Serves to confer a new Specificity to the catalytic domain by increasing the effective (22) Filed: Aug. 27, 2003 local concentration of the target in the vicinity of the catalytic domain. The present invention also provides phar Related U.S. Application Data maceutical compositions comprising these adzymes, meth ods of making adzymes, DNA's encoding adzymes or parts (60) Provisional application No. 60/406,517, filed on Aug. thereof, and methods of using adzymes, Such as for treating 27, 2002. Provisional application No. 60/423,754, human Subjects Suffering from a disease, Such as a disease filed on Nov.
    [Show full text]
  • A Genomic Analysis of Rat Proteases and Protease Inhibitors
    A genomic analysis of rat proteases and protease inhibitors Xose S. Puente and Carlos López-Otín Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain Send correspondence to: Carlos López-Otín Departamento de Bioquímica y Biología Molecular Facultad de Medicina, Universidad de Oviedo 33006 Oviedo-SPAIN Tel. 34-985-104201; Fax: 34-985-103564 E-mail: [email protected] Proteases perform fundamental roles in multiple biological processes and are associated with a growing number of pathological conditions that involve abnormal or deficient functions of these enzymes. The availability of the rat genome sequence has opened the possibility to perform a global analysis of the complete protease repertoire or degradome of this model organism. The rat degradome consists of at least 626 proteases and homologs, which are distributed into five catalytic classes: 24 aspartic, 160 cysteine, 192 metallo, 221 serine, and 29 threonine proteases. Overall, this distribution is similar to that of the mouse degradome, but significatively more complex than that corresponding to the human degradome composed of 561 proteases and homologs. This increased complexity of the rat protease complement mainly derives from the expansion of several gene families including placental cathepsins, testases, kallikreins and hematopoietic serine proteases, involved in reproductive or immunological functions. These protease families have also evolved differently in the rat and mouse genomes and may contribute to explain some functional differences between these two closely related species. Likewise, genomic analysis of rat protease inhibitors has shown some differences with the mouse protease inhibitor complement and the marked expansion of families of cysteine and serine protease inhibitors in rat and mouse with respect to human.
    [Show full text]
  • Myeloid Cell Expressed Proprotein Convertase FURIN Attenuates Inflammation
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 34 Research Paper: Immunology Myeloid cell expressed proprotein convertase FURIN attenuates inflammation Zuzet Martinez Cordova1, Anna Grönholm1, Ville Kytölä2, Valentina Taverniti3, Sanna Hämäläinen1, Saara Aittomäki1, Wilhelmiina Niininen1, Ilkka Junttila4,5, Antti Ylipää2, Matti Nykter2 and Marko Pesu1,6 1 Team Immunoregulation, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere, Tampere, Finland 2 Team Computational Biology, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere, Tampere, Finland 3 Department of Food, Environmental and Nutritional Sciences (DeFENS), Division of Food Microbiology and Bioprocessing, Università degli Studi di Milano, Milan, Italy 4 School of Medicine, University of Tampere, Tampere, Finland 5 Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland 6 Department of Dermatology, Tampere University Hospital, Tampere, Finland Correspondence to: Marko Pesu, email: [email protected] Keywords: cytokine, FURIN, LysM, macrophage, TGF-β1, Immunology and Microbiology Section, Immune response, Immunity Received: February 25, 2016 Accepted: July 22, 2016 Published: August 05, 2016 ABSTRACT The proprotein convertase enzyme FURIN processes immature pro-proteins into functional end- products. FURIN is upregulated in activated immune cells and it regulates T-cell dependent peripheral tolerance and the Th1/Th2 balance. FURIN also promotes the infectivity of pathogens by activating bacterial toxins and by processing viral proteins. Here, we evaluated the role of FURIN in LysM+ myeloid cells in vivo. Mice with a conditional deletion of FURIN in their myeloid cells (LysMCre-fur(fl/fl)) were healthy and showed unchanged proportions of neutrophils and macrophages. Instead, LysMCre-fur(fl/fl) mice had elevated serum IL-1β levels and reduced numbers of splenocytes.
    [Show full text]
  • Hysteretic Behavior of Proprotein Convertase 1/3 (PC1/3)
    Hysteretic Behavior of Proprotein Convertase 1/3 (PC1/3) Marcelo Y. Icimoto1, Nilana M. Barros2, Juliana C. Ferreira1, Marcelo F. Marcondes1, Douglas Andrade1, Mauricio F. Machado1, Maria A. Juliano1, Wagner A. Ju´ dice3, Luiz Juliano1, Vitor Oliveira1* 1 Departamento de Biofı´sica, Universidade Federal de Sa˜o Paulo, Sa˜o Paulo, Brazil, 2 Cieˆncias Exatas e da Terra, Universidade Federal de Sa˜o Paulo, Sa˜o Paulo, Brazil, 3 Centro Interdisciplinar de Investigac¸a˜o Bioquı´mica, Universidade de Mogi das Cruzes, Sa˜o Paulo, Brazil Abstract The proprotein convertases (PCs) are calcium-dependent proteases responsible for processing precursor proteins into their active forms in eukariotes. The PC1/3 is a pivotal enzyme of this family that participates in the proteolytic maturation of prohormones and neuropeptides inside the regulated secretory pathway. In this paper we demonstrate that mouse proprotein convertase 1/3 (mPC1/3) has a lag phase of activation by substrates that can be interpreted as a hysteretic behavior of the enzyme for their hydrolysis. This is an unprecedented observation in peptidases, but is frequent in regulatory enzymes with physiological relevance. The lag phase of mPC1/3 is dependent on substrate, calcium concentration and pH. This hysteretic behavior may have implications in the physiological processes in which PC1/3 participates and could be considered an additional control step in the peptide hormone maturation processes as for instance in the transformation of proinsulin to insulin. Citation: Icimoto MY, Barros NM, Ferreira JC, Marcondes MF, Andrade D, et al. (2011) Hysteretic Behavior of Proprotein Convertase 1/3 (PC1/3). PLoS ONE 6(9): e24545.
    [Show full text]